When was NuPulseCV founded?

NuPulseCV was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Where is NuPulseCV located?

NuPulseCV is headquartered in Raleigh, United States. It is registered at Raleigh, North Carolina.

Who is the current CEO of NuPulseCV?

Douglas H Altschuler and Sonna P. s of NuPulseCV. Douglas H Altschuler has also founded 1 company.

How many employees does NuPulseCV have?

As of Mar 31, 2026, the latest employee count at NuPulseCV is 21.

Is NuPulseCV a funded company?

NuPulseCV is a funded company, having raised a total of $14.2M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 12, 2014.

When was the latest funding round of NuPulseCV?

NuPulseCV's latest funding was a $***** Grant (prize money) round on Jul 01, 2021, with participation from 1 investor.

Where does NuPulseCV rank among its competitors?

NuPulseCV ranks 32nd amongst 99 active competitors, of which 58 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was FineHeart, which secured $40.8M in Jan, 2026.

Who are the top competitors of NuPulseCV?

NuPulseCV's top competitors include CVRx, Impulse Dynamics and CorWave. Among them, FineHeart secured the most recent funding round in January, 2026.

NuPulseCV - 2026 Company Profile, Team, Funding & Competitors

Company Details

Transforming chronic heart failure treatment with minimally invasive cardiac assist devices. This company is dedicated to revolutionizing the management of chronic heart failure through innovative cardiac assist technology. They are focused on developing and delivering minimally invasive, long-term cardiac assist devices designed to improve the lives of patients. Their flagship product is a heart pump that allows patients to be discharged home, promoting recovery and enabling them to resume daily activities. This approach utilizes the physiological principles of counterpulsation, offering a unique treatment option for chronic heart failure patients. The company is currently preparing for a pivotal trial to support market approval, aiming to provide a solution for individuals awaiting heart transplants or those with limited treatment options. They are a clinical stage medical device company.

Website: nupulsecv.com
Email ID: *****@nupulsecv.com
Registered Address: Raleigh, North Carolina

Key Metrics

Founded Year

2011

Location

Raleigh, United States

Stage

Series A

Total Funding

$14.2M in 6 rounds

Latest Funding Round

Grant (prize money), Jul 01, 2021, $*****

Investors

Valera Capital & 2 more

Ranked

32^nd among 99 active competitors

Employee Count

21 as on Mar 31, 2026

Similar Companies

CVRx & 125 more

View NuPulseCV's full profile

NuPulseCV is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Nupulsecv, Inc. CIN: 454760204 , United States, Active	Dec 31, 2010	-	16 (As on Dec 31, 2024)	-

NuPulseCV has raised a total funding of $14.2M over 6 rounds. Its first funding round was on Aug 12, 2014. Its latest funding round was a Grant (prize money) round on Jul 01, 2021 for $*****. 1 investor participated in its latest round. NuPulseCV has 3 institutional investors.

Here is the list of recent funding rounds of NuPulseCV:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 01, 2021	8310182	Grant (prize money)	3516437	9188057	4484951	6177901
Mar 24, 2020	8771800	Series A	8363257	7466706	7387545	2259240
Jul 01, 2019	9557672	Grant (prize money)	4321015	3907202	7807031	HHS

Access funding benchmarks and valuations. Sign up today!

View details of NuPulseCV's funding rounds and investors

The founders of NuPulseCV is Douglas H Altschuler. Douglas H Altschuler is the CEO of NuPulseCV.

Here are the details of NuPulseCV's key team members:

Douglas H Altschuler: Founder & CEO of NuPulseCV.
Contact Info: 1 email address
Sonna P.: CEO of NuPulseCV.

NuPulseCV's Board of Directors

NuPulseCV's board has 10 active members. Greg Scott, Richard Sherman, Brian Novack, Dirk Simmons, Sonna Patel-Raman, Douglas Godshall, VALLUVAN JEEVANANDAM, Alex Shlyankevich, Douglas Altschuler and Brian Novak are independent board members.

Here is the list of NuPulseCV's board of directors:

Name	Type	Representing	Status	Duration
Greg Scott	Independent board member	-	Current	8y 0m
ifddhgn	Independent board member	-	Current	9y 2m
jypahlo	Independent board member	-	Current	9y 3m
zqfqjkl	Independent board member	-	Current	6y 8m
uxluehe	Independent board member	-	Current	4y 8m
nxuxm{p	Independent board member	-	Current	1y 2m
yxu{kuh	Independent board member	-	Current	7y 2m
th{kvuk	Independent board member	-	Current	4y 4m
ygmzjjp	Independent board member	-	Current	2y 8m
srtzapn	Independent board member	-	Current	7y 2m

View details of NuPulseCV's Founder profiles and Board Members

NuPulseCV's employee count trend

NuPulseCV has 21 employees as of Mar 26. Here is NuPulseCV's employee count trend over the years:

Uncover NuPulseCV's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NuPulseCV include CVRx, Impulse Dynamics and CorWave. Here is the list of Top 10 competitors of NuPulseCV, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CVRx 2001, Minneapolis (United States), Public	Developer of implantable technology for hypertension and heart failure	$394M	Johnson & Johnson Innovation – JJDC, New Enterprise Associates ... & 20 others	68/100
2nd	Impulse Dynamics 1998, Marlton (United States), Series F	Provider of implantable device for treatment of chronic heart failure	$685M	Perceptive Advisors, Amzak Health & 16 others	64/100
3rd	CorWave 2011, Paris (France), Series C	Developer of implantable blood pumps for the treatment of heart failure	$127M	Novo Holdings, Bpifrance & 11 others	61/100
4th	Element Science 2013, San Francisco (United States), Series C	Wearable therapeutic device for treating sudden cardiac arrest	$193M	Deerfield, Qiming & 4 others	61/100
5th	SynCardia 2001, Tucson (United States), Public	Artificial heart	$72M	Athyrium Capital Management, SWK Holdings ... & 5 others	60/100
6th	InterShunt Technologies 2015, Louisiana (United States), Series B	Developer of cardiac catheter for the treatment of cardiac diseases	$26.6M	Solas BioVentures, Gener8tor & 6 others	46/100
7th	FineHeart 2010, Pessac (France), Series C	Developer of an implantable cardiovascular device for treating heart failures	$51.9M	Verve Ventures, Broadview Ventures & 16 others	57/100
8th	Reprieve Cardiovascular 2018, Milford (United States), Series B	Developer of decongestion management solution for acute decompensated heart failure patients	$150M	Deerfield, Arboretum Ventures & 8 others	56/100
9th	Bivacor 2008, Houston (United States), Series B	Developer of ventricular assist device (VAD)	$28M	Cormorant Asset Management, One Ventures & 3 others	56/100
10th	Procyrion 2005, Houston (United States), Series E	Developing percutaneous mechanical circulatory support for heart failure and cardiorenal syndrome	$114M	Fannin Innovation Studio, Scientific Health Development ... & 4 others	54/100
32nd	NuPulseCV 2011, Raleigh (United States), Series A	Transforming chronic heart failure treatment with minimally invasive cardiac assist devices	$14.2M	Valera Capital, Broadview Ventures & 1 others	40/100